Synthetech Announces Date for its First Quarter Fiscal 2011 Earnings Release and Conference Call

ALBANY, Ore., Aug. 3 /PRNewswire-FirstCall/ -- Synthetech, Inc. (OTC Bulletin Board: NZYM) today announced it will issue first quarter fiscal 2011 financial results before the opening of the market on Friday, August 6, 2010. Synthetech's first quarter for its fiscal year ending March 31, 2011 concluded on June 30, 2010.  Following the release of its financial results, Synthetech will host a conference call at 1:30 p.m. PT.  Dr. Gregory Hahn, President and CEO, along with Gary Weber, Senior Vice President and CFO, will discuss results and be available to answer related questions.

The conference call can be accessed by dialing 877-524-1203 at 1:15 p.m. PT and entering code 413413.  Replays of the audio only conference will be available after the call via the investor area of Synthetech's website at www.synthetech.com.

About Synthetech

Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies.  We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and proprietary custom chiral intermediates, primarily for the pharmaceutical industry.  Synthetech produces advanced pharmaceutical intermediates in accordance with Current Good Manufacturing Practices (cGMP) in compliance with U.S. Food and Drug Administration (FDA) regulations.  Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production.  Synthetech's products also support the production of chemically-based medical devices.  Synthetech's domestic and international customer base includes major pharmaceutical, contract drug synthesis firms, emerging biotechnology (virtual pharmaceutical) and medical device companies.  We also supply catalog quantities of specialty amino acids to research institutions, universities and drug discovery firms.

SOURCE Synthetech, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED